A F Cicero

Summary

Country: Italy

Publications

  1. ncbi Serum lipopotein (a) levels in a large sample of subjects affected by familial combined hyperlipoproteinaemia and in general population
    Arrigo F G Cicero
    Atherosclerosis Study Center G Descovich, Clinical Medicine and Applied Biotechnologies, Dept D Campanacci, University of Bologna, Italy
    J Cardiovasc Risk 10:149-51. 2003
  2. ncbi Rice bran oil and gamma-oryzanol in the treatment of hyperlipoproteinaemias and other conditions
    A F Cicero
    Atherosclerosis and Dysmetabolic Disease Study Center G Descovich, Clinical Medicine and Applied Biotechnology Dept D Campanacci, University of Bologna, Italy
    Phytother Res 15:277-89. 2001
  3. ncbi [Cardiovascular risk factors in severely ill psychiatric patients]
    Arrigo F G Cicero
    Centro per lo studio dell aterosclerosi e delle malattie dismetaboliche GC Descovichi, Ospedale Sant Orsola Malpighi Bologna
    Epidemiol Prev 27:40-3. 2003
  4. ncbi Effects of a new soy/beta-sitosterol supplement on plasma lipids in moderately hypercholesterolemic subjects
    Arrigo F G Cicero
    Atherosclerosis and Dysmetabolic Disease Study Center G Descovich, Clinical Medicine and Applied Biotechnologies D Campanacci, University of Bologna, Italy
    J Am Diet Assoc 102:1807-11. 2002
  5. ncbi Panax notoginseng (Burk.) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet
    A F G Cicero
    Athensclensis Study Center, G Descovich, University of Bologna, Italy
    Phytother Res 17:174-8. 2003
  6. ncbi The realization of a project aimed at reducing the plasmatic lipid level in a large Italian population improves the mean calcium daily intake: the Brisighella Study
    A Gaddi
    Atherosclerosis and Metabolic Diseases Study Centre G Descovich, Department of Internal Medicine and Applied Biotechnology, University of Bologna, Italy
    Eur J Clin Nutr 55:97-106. 2001
  7. ncbi Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico S Matteo, Pavia, Italy
    Endothelium 14:45-51. 2007
  8. ncbi Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure
    Claudio Borghi
    Department of Internal Medicine, University of Bologna, Bologna, Italy
    J Hypertens 25:2051-7. 2007
  9. ncbi Antihyperlipidaemic effect of a Monascus purpureus brand dietary supplement on a large sample of subjects at low risk for cardiovascular disease: a pilot study
    Arrigo F G Cicero
    Department of Internal Medicine and Applied Biotechnology, Atherosclerosis and Metabolic Diseases Study Centre G Descovich, University of Bologna, S Orsola Malpighi University Hospital Via Massarenti, 9 40138 Bologna, Italy
    Complement Ther Med 13:273-8. 2005
  10. ncbi Changes in LDL fatty acid composition as a response to olive oil treatment are inversely related to lipid oxidative damage: The EUROLIVE study
    Arrigo F G Cicero
    GC Descovich Atherosclerosis and Metabolic Disease Research Unit, Internal Medicine, Aging and Kidney Diseases Dept, University of Bologna, Via Massarenti, 9, 40138 Bologna, Italy
    J Am Coll Nutr 27:314-20. 2008

Detail Information

Publications34

  1. ncbi Serum lipopotein (a) levels in a large sample of subjects affected by familial combined hyperlipoproteinaemia and in general population
    Arrigo F G Cicero
    Atherosclerosis Study Center G Descovich, Clinical Medicine and Applied Biotechnologies, Dept D Campanacci, University of Bologna, Italy
    J Cardiovasc Risk 10:149-51. 2003
    ..Serum lipoprotein (a) [Lp(a)] is a lipidic parameter, strictly under genetic control. Lp(a) levels vary in different dyslipidaemias according to the underlying disease...
  2. ncbi Rice bran oil and gamma-oryzanol in the treatment of hyperlipoproteinaemias and other conditions
    A F Cicero
    Atherosclerosis and Dysmetabolic Disease Study Center G Descovich, Clinical Medicine and Applied Biotechnology Dept D Campanacci, University of Bologna, Italy
    Phytother Res 15:277-89. 2001
    ..This paper reviews the available data on the pharmacology and toxicology of rice bran oil and its main components with particular attention to those studies relating to plasma lipid altering effects...
  3. ncbi [Cardiovascular risk factors in severely ill psychiatric patients]
    Arrigo F G Cicero
    Centro per lo studio dell aterosclerosi e delle malattie dismetaboliche GC Descovichi, Ospedale Sant Orsola Malpighi Bologna
    Epidemiol Prev 27:40-3. 2003
    ..Thus, we find unethical do not treat hypertension, dyslipidemia and diabetes in severe psychiatric patients...
  4. ncbi Effects of a new soy/beta-sitosterol supplement on plasma lipids in moderately hypercholesterolemic subjects
    Arrigo F G Cicero
    Atherosclerosis and Dysmetabolic Disease Study Center G Descovich, Clinical Medicine and Applied Biotechnologies D Campanacci, University of Bologna, Italy
    J Am Diet Assoc 102:1807-11. 2002
    ..According to this recommends, low doses of soy protein added in b-sitosterol seems to be a practical and safe alternative for patients seeking modest reductions in LDL-C (< 15%)...
  5. ncbi Panax notoginseng (Burk.) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet
    A F G Cicero
    Athensclensis Study Center, G Descovich, University of Bologna, Italy
    Phytother Res 17:174-8. 2003
    ..Besides a moderate, non dose-related decrease in the plasma lipid levels, P. notoginseng appeared to induce a significant reduction in the rat fibrinogenaemia...
  6. ncbi The realization of a project aimed at reducing the plasmatic lipid level in a large Italian population improves the mean calcium daily intake: the Brisighella Study
    A Gaddi
    Atherosclerosis and Metabolic Diseases Study Centre G Descovich, Department of Internal Medicine and Applied Biotechnology, University of Bologna, Italy
    Eur J Clin Nutr 55:97-106. 2001
    ..Evaluation of the impact of a coronary heart disease prevention program on calcium, magnesium, phosphorus and vitamin D dietary intake in respect of recommended daily allowances in a large Italian rural population...
  7. ncbi Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico S Matteo, Pavia, Italy
    Endothelium 14:45-51. 2007
    ..MMP-9, TIMP-1, and TIMP-2 plasma levels were increased in diabetic patients with ACSs, which may reflect abnormal extracellular matrix metabolism in diabetes during acute event...
  8. ncbi Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure
    Claudio Borghi
    Department of Internal Medicine, University of Bologna, Bologna, Italy
    J Hypertens 25:2051-7. 2007
    ..To investigate the possible interactions between serum cholesterol levels and the renin-angiotensin system on the development of stable hypertension in subjects with high-normal blood pressure (BP)...
  9. ncbi Antihyperlipidaemic effect of a Monascus purpureus brand dietary supplement on a large sample of subjects at low risk for cardiovascular disease: a pilot study
    Arrigo F G Cicero
    Department of Internal Medicine and Applied Biotechnology, Atherosclerosis and Metabolic Diseases Study Centre G Descovich, University of Bologna, S Orsola Malpighi University Hospital Via Massarenti, 9 40138 Bologna, Italy
    Complement Ther Med 13:273-8. 2005
    ....
  10. ncbi Changes in LDL fatty acid composition as a response to olive oil treatment are inversely related to lipid oxidative damage: The EUROLIVE study
    Arrigo F G Cicero
    GC Descovich Atherosclerosis and Metabolic Disease Research Unit, Internal Medicine, Aging and Kidney Diseases Dept, University of Bologna, Via Massarenti, 9, 40138 Bologna, Italy
    J Am Coll Nutr 27:314-20. 2008
    ..The aim of our study was to assess the changes in the fatty acid composition of low density lipoproteins (LDL) after sustained consumption of olive oil at real-life doses (25 mL/day) and their relationship with lipid oxidative damage...
  11. ncbi Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, doubl
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    Clin Ther 26:1228-36. 2004
    ..Angiotensin receptor blockers (ARBs) provide effective blood pressure control. Whereas none of the ARBs appear to affect glucose homeostasis, some ARBs have been associated with a decrease in cholesterolemia...
  12. ncbi Effects of a new low dose soy protein/beta-sitosterol association on plasma lipid levels and oxidation
    Arrigo F G Cicero
    Atherosclerosis and Metabolic Diseases Study Centre G Descovich, Clinical Medicine and Applied Biotechnology, Dept D Campanacci, S Orsola Malpighi University Hospital, Via Massarenti, 9, 40138 Bologna, Italy
    Eur J Nutr 43:319-22. 2004
    ..High doses of soy protein are able to decrease plasma cholesterolemia significantly, but they unbalance daily protein intake and strongly modify nutritional habits in patients...
  13. ncbi Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Piazzale C Golgi 2, 27100 Pavia, Italy
    Clin Ther 26:744-54. 2004
    ..Glimepiride is approved as monotherapy and in combination with metformin or with insulin, whereas the combination of glimepiride with other antihyperglycemic drugs is under investigation...
  14. ncbi Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation
    Arrigo F G Cicero
    G Descovich Atherosclerosis and Dysmetabolic Disease Research Center, D Campanacci Clinical Medicine and Applied Biotechnology Department, University of Bologna, Bologna, Italy
    Arzneimittelforschung 57:26-30. 2007
    ....
  15. ncbi Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    Hypertens Res 29:849-56. 2006
    ..These observed metabolic effects of different angiotensin type 1 receptor blockers could be relevant when choosing a therapy to correct metabolic derangement of patients affected by metabolic syndrome and diabetes...
  16. ncbi Asymptomatic massive hypertriglyceridemia in an octogenarian
    Arrigo F G Cicero
    Atherosclerosis and Metabolism Diseases Study Centre GC Descovich, Clinical Medicine and Applied Biotechnology Department D Campanacci, University of Bologna, Italy
    Med Princ Pract 12:51-3. 2003
    ..To report the case of an 85-year-old man with asymptomatic massive hypertriglyceridemia (MHTG)...
  17. ncbi Blood pressure control and inflammatory markers in type 2 diabetic patients treated with pioglitazone or rosiglitazone and metformin
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico S Matteo, Pavia, Italy
    Hypertens Res 30:387-94. 2007
    ....
  18. ncbi Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial
    Giuseppe Derosa
    Department o f Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico S Matteo, Pavia, Italy
    Clin Ther 29:602-10. 2007
    ..The autonomic nervous system plays an important part in the homeostasis of blood pressure (BP), and sympathetic overactivity may contribute to metabolic conditions such as glycemic intolerance or insulin resistance...
  19. ncbi Cerebrovascular disease in Italy and Europe: it is necessary to prevent a 'pandemia'
    Antonio Gaddi
    Atherosclerosis and Dysmetabolic Disease Study Centre G Descovich, University of Bologna, Italy
    J Cardiovasc Risk 9:143-5. 2002
    ..It is plausible that the application of a suitable early prevention of the cerebrovascular pathology could bring to a more late slatentisation and less serious demonstrations of Alzheimer's disease, when this is destined to develop...
  20. ncbi Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease
    Arrigo F G Cicero
    GC Descovich Atherosclerosis and Metabolic Disease Research Unit, D Campanacci Clinical Medicine and Applied Biotechnology Department, Alma Mater Studiorum University of Bologna, Bologna, Italy
    Endothelium 14:193-8. 2007
    ..However, the superposition of MS on FCH further increases the plasma level of these parameters. The prognostic value of this observation has to be evaluated...
  21. ncbi Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico S Matteo, Pavia, Italy
    Heart Vessels 22:361-70. 2007
    ..In conclusion, MMP-2, MMP-9, TIMP-1, and TIMP-2 plasma levels were higher in diabetic, ACS, and DACS patients, which may reflect abnormal extracellular matrix metabolism in diabetes and in acute coronary syndrome...
  22. ncbi Persistence on treatment and blood pressure control with different first-line antihypertensive treatments: a prospective evaluation
    Maria Grazia Prandin
    D Campanacci Clinical Medicine and Applied Biotechnology Department, Alma Mater Studiorum, University of Bologna, Italy
    Clin Exp Hypertens 29:553-62. 2007
    ..46.6%). Systolic and diastolic BP decreased more in patients treated with ARBs (-11.2/-5.8 mmHg), ACE inhibitors (-10.5/-5.1 mmHg), and CCBs (-8.5/-4.6 mmHg) when compared to beta-blockers (-4.0/-2.3 mmHg) and diuretics (-2.3/-2.1 mmHg)...
  23. ncbi Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data
    Claudio Borghi
    Hypertension Research Center, D Campanacci Clinical Medicine and Applied Biotechnology Department, Alma Mater Studiorum, University of Bologna, Italy
    Vasc Health Risk Manag 2:341-9. 2006
    ....
  24. ncbi Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    Clin Drug Investig 26:529-39. 2006
    ..The aim of this study was to evaluate if the expected improvement in glucose and lipid metabolism obtainable with doxazosin is or is not synergistic with standard antihyperglycaemic treatment using the alpha-glucosidase inhibitor acarbose...
  25. ncbi A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, IRCCS Policlinico S Matteo, Pavia, Italy
    Clin Ther 25:2006-21. 2003
    ....
  26. ncbi Effect of oral chronic isoflavones supplementation on male rat sexual performances and sexual hormone plasma levels
    Arrigo F G Cicero
    Biomedical Sciences Department, Pharmacology Section, University of Modena and Reggio nell emilia, Modena, Italy
    Phytother Res 18:849-52. 2004
    ..No significant difference has been observed as regards FSH, progesterone, androstenedione plasma levels, either between groups or between baseline and study end. Slight differences were found regards LH and testosterone plasma level...
  27. ncbi Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Italy
    Pharmacotherapy 25:637-45. 2005
    ....
  28. ncbi A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, P le C Golgi, 2 27100 Pavia, Italy
    Diabetes Res Clin Pract 69:5-13. 2005
    ..To compare the effects of glimepiride plus pioglitazone or plus rosiglitazone in diabetic patients with the metabolic syndrome on coagulation and fibrinolysis parameters...
  29. ncbi The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    Clin Ther 25:1429-39. 2003
    ..A previous study has demonstrated that L-carnitine reduces plasma lipoprotein(a) (Lp[a]) levels in patients with hypercholesterolemia...
  30. ncbi Hypercholesterolemia underdiagnosis and undertreatment in psychiatric patients in Italy
    Arrigo F G Cicero
    Eur J Epidemiol 18:373-4. 2003
  31. ncbi Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    Endothelium 13:227-31. 2006
    ..0001) and for TIMP-1 (p < .0001) in hypertensive patients. Plasma levels and activities of MMP-2, MMP-9, and TIMP-1 are increased in hypertensive patients, which may reflect abnormal ECM metabolism...
  32. ncbi Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    Clin Ther 28:679-88. 2006
    ....
  33. ncbi Prospects for the development of novel anti-hyperlipidemic drugs
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Italy
    Curr Opin Investig Drugs 7:826-33. 2006
    ....
  34. ncbi Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    Clin Ther 27:1383-91. 2005
    ..Based on a literature search, few direct comparisons of different antihyperglycemic treatments on blood pressure have been reported...